Tinder, OKCupid, Match, other dating sites will give a bump to users who get vaccinated

States and local entities are offering all sorts of incentives to get inoculated against COVID-19 — beer, food, lottery tickets, dinner with New Jersey's governor — as vaccination rates plateau or decline across much of the U.S. The White House is looking to leverage love — or at least libido — to boost vaccination rates.
In a collaboration announced Friday, the White House and nine dating sites under the Match Group umbrella are launching a campaign to boost dating customers who get vaccinated, are already vaccinated — or maybe just say the are vaccinated. Details "will be available in the coming weeks," the Match Group said.
The nine sites — Tinder, OKCupid, Match, Bumble, Hinge, BLK, Chispa, Plenty of Fish, and Badoo — will offer various ways of making people with vaccine-related badges or profile markers more attractive to prospective dates. The various sites will launch their campaigns soon and run them through July 4, the date at which President Biden wants 70 percent of all adults to be at least partially vaccinated. Proof of vaccination will get love-seekers "like boosts, super likes, and super swipes," the White House said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The dating apps and White House say they are just following current market forces. "According to research from OKCupid, people who are vaccinated or plan to get vaccinated receive 14 percent more Matches than people who don't plan to get vaccinated," the White House said in a fact sheet.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Why is MAGA turning on Amy Coney Barrett?
Today's Big Question She may be the swing vote on Trump cases
By Joel Mathis, The Week US Published
-
Gavin Newsom's podcast debut is not going over well with some liberals
IN THE SPOTLIGHT The first episode of the California Governor and potential presidential candidate's 'This is Gavin Newsom' featured cozy conversation with far-right operative Charlie Kirk and a surprisingly conservative stance on transgender athletes
By Rafi Schwartz, The Week US Published
-
'Extremists still find plenty of digital spaces'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published